POICX
Price
$11.66
Change
+$0.02 (+0.17%)
Updated
Jul 25 closing price
Net Assets
651.8M
RLBCX
Price
$36.95
Change
+$0.07 (+0.19%)
Updated
Jul 25 closing price
Net Assets
254.37B
Interact to see
Advertisement

POICX vs RLBCX

Header iconPOICX vs RLBCX Comparison
Open Charts POICX vs RLBCXBanner chart's image
Virtus Tactical Allocation C
Price$11.66
Change+$0.02 (+0.17%)
VolumeN/A
Net Assets651.8M
American Funds American Balanced R3
Price$36.95
Change+$0.07 (+0.19%)
VolumeN/A
Net Assets254.37B
POICX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
POICX vs. RLBCX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is POICX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 254B vs. POICX (652M). RLBCX pays higher dividends than POICX: RLBCX (1.57) vs POICX (0.83). POICX was incepted earlier than RLBCX: POICX (26 years) vs RLBCX (23 years). POICX (1.87) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. POICX (37.00). RLBCX has a lower initial minimum investment than POICX: RLBCX (250) vs POICX (2500). RLBCX annual gain was more profitable for investors over the last year : 9.89 vs. POICX (2.57). RLBCX return over 5 years is better than : 37.80 vs. POICX (2.55).
POICXRLBCXPOICX / RLBCX
Total Expense Ratio1.750.89197%
Annual Report Gross Expense Ratio1.870.89210%
Fund Existence26 years23 years-
Gain YTD7.9088.83090%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets652M254B0%
Annual Yield % from dividends0.831.5753%
Returns for 1 year2.579.8926%
Returns for 3 years21.8633.6565%
Returns for 5 years2.5537.807%
Returns for 10 years29.6362.1348%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UK1.040.06
+6.12%
Ucommune International Ltd
ARCB86.212.06
+2.45%
ArcBest Corp
NLY20.860.30
+1.46%
Annaly Capital Management
DAVE210.611.62
+0.78%
Dave
PYXS1.25-0.09
-6.72%
Pyxis Oncology